Trial Profile
A Phase 1 Study of Palbociclib in Combination With Cisplatin or Carboplatin in Advanced Solid Malignancies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Oct 2023
Price :
$35
*
At a glance
- Drugs Palbociclib (Primary) ; Carboplatin; Cisplatin
- Indications Advanced breast cancer; Biliary cancer; Gastric cancer; Male breast cancer; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Prostate cancer; Solid tumours; Squamous cell cancer
- Focus Adverse reactions
- 06 Oct 2023 Status changed from active, no longer recruiting to completed.
- 03 Jan 2023 Planned End Date changed from 1 Dec 2023 to 24 Dec 2024.
- 03 Jan 2023 Planned primary completion date changed from 1 Dec 2022 to 24 Dec 2023.